According to the research report titled ‘Global Continuous Glucose Monitoring Devices (CGM) Market: Analysis By Component (Transmitter & Receiver, Sensor, Integrated Insulin Pump), By Demographics, End-User, By Region, By Country (2018 Edition): Forecast to 2023’ available with Market Study Report, the global continuous glucose monitoring devices market is estimated to grow with a CAGR of 21.25% during the period of 2018-2023.
 

For the record, continuous glucose monitoring (CGM) is a process of tracking glucose levels in the body throughout the day. The system measures glucose levels at regular intervals and interpret the readings into dynamic data. This facilitates to measure the rate of change in glucose percentage in the body.
 

Growing occurrences of chronic diabetes, coupled with rising medical awareness among consumers and booming market for minimally invasive products are driving the growth of CGM devices market. Surging investments in healthcare advancements across the globe, introduction of new devices, and rising elderly diabetic population will further augment the demand for CGM devices.
 

As per type of component, CGM devices market is categorized into sensors, transmitter & receiver, and integrated insulin pumps, in which the transmitter & receiver segment is expected to dominate the market over the analysis period. While talking about demographics, the market is divided into adult and pediatric. Based on end-user spectrum, the industry is fragmented into hospital and homecare.
 

Considering the geographical landscape, the global CGM devices market is divided into regions namely, Europe, North America, APAC and rest of the world, with primary focus on countries such as Canada, US, Germany, Japan, India, UK, Brazil and China. According to the report, North America CGM devices market held the largest regional share in 2018. However, due to substantial customer base and increase in healthcare expenditure, especially in developing countries such as India and China, Asia Pacific CGM devices market is projected to show significant growth over the forecast period. 
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/1290091/
 

The key players in the global CGM devices market are Dexcom, Medtronic, AgaMatrix Inc., Abbott Laboratories, Senseonics Holdings, Integrity Applications, Insulet Corp., and GlySens ICGM.
 

Notably, the research report provides crucial statistics and data on the CGM devices market current size, position and growth factors. It also delivers insights about the market dynamics and competitive landscape.